Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Detection of Right and Left Ventricular Dysfunction in Pediatric Patients Using Artificial Intelligence–Enabled ECGs
Anjewierden, Scott , O’Sullivan, Donnchadh , Mangold, Kathryn, Greason, Grace , Attia, Zachi I. , López-Jiménez, Francisco , Friedman, Paul A. , Asirvatham, Samuel J. , Anderson, Jason H. , Eidem, Benjamin W., Johnson, Jonathan N. , Prakash, Shisheer Havangi, Madhavan, Malini , Mangold, Kathryn E , Attia, Zachi I , Anderson, Jason , Havangi Prakash, Shisheer, Niaz, Talha , Madhavan, Malini , Asirvatham, Samuel J , Lopez-Jimenez, Francisco , Niaz, Talha

Journal of the American Heart Association | November 4, 2024 | Volume: 13 | Issue: 21 | Pages: No page available

10.1161/jaha.124.035201 | PMID 39494568 Get It

Background Early detection of left and right ventricular systolic dysfunction (LVSD and RVSD respectively) in children can lead to intervention to reduce morbidity and death. Existing artificial intelligence algorithms can identify LVSD and RVSD in adults using a 12‐lead ECG; however, its efficacy in children is uncertain. We aimed to develop novel artificial intelligence–enabled ECG algorithms for LVSD and RVSD detection in pediatric patients. Methods and Results We identified 10 142 unique pediatric patients (age≤18) with a 10‐second, 12‐lead surface ECG within 14 days of a transthoracic echocardiogram, performed between 2002 and 2022. LVSD was defined quantitatively by left ventricular ejection fraction (LVEF). RVSD was defined semiquantitatively. Novel pediatric models for LVEF ≤35% and LVEF <50% achieved excellent test areas under the curve of 0.93 (95% CI, 0.89–0.98) and 0.88 (95% CI, 0.83–0.94) respectively. The model to detect LVEF <50% had a sensitivity of 0.85, specificity of 0.80, positive predictive value of 0.095, and negative predictive value of 0.995. In comparison, the previously validated adult data‐derived model for LVEF <35% achieved an area under the curve of 0.87 (95% CI, 0.84–0.90) for LVEF ≤35% in children. A novel pediatric model for any RVSD detection reached a test area under the curve of 0.90 (0.87–0.94). Conclusions An artificial intelligence–enabled ECG demonstrates accurate detection of both LVSD and RVSD in pediatric patients. While adult‐trained models offer good performance, improvements are seen when training pediatric‐specific models.
Invasive Versus Conservative Strategy in Older Adults ≥75 Years of Age With Non–ST‐segment–Elevation Acute Coronary Syndrome: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Rout, Amit , Moumneh, Mohamad Bahij , Kalra, Kriti , Singh, Sahib , Garg, Aakash , Kunadian, Vijay , Alkhouli, Mohamad , Batchelor, Wayne , Biscaglia, Simone , Alkhouli, Mohamad , Rymer, Jennifer A , Batchelor, Wayne B , Nanna, Michael G , Damluji, Abdulla A , Kunadian, Vijay , Nanna, Michael G.

Journal of the American Heart Association | November 4, 2024 | Volume: 13 | Issue: 21 | Pages: No page available

10.1161/jaha.124.036151 | PMID 39494560 Get It

Background Older adults with non–ST‐segment–elevation acute coronary syndrome are less likely to undergo an invasive strategy compared with younger patients. Randomized controlled trials traditionally exclude older adults because of their high burden of geriatric conditions. Methods and Results We searched for randomized controlled trials comparing invasive versus medical management or a selective invasive (conservative) strategy for older patients (age≥75 years) with non–ST‐segment–elevation acute coronary syndrome. Fixed effects meta‐analysis was conducted to estimate the odds ratio (OR) with 95% CI for the composite of death or myocardial infarction (MI) and individual secondary end points of all‐cause death, cardiovascular death, MI, revascularization, stroke, and major bleeding. Nine studies with 2429 patients (invasive: 1228 versus control: 1201) with a mean follow‐up of 21 months were included. An invasive strategy was associated with a significantly decreased risk of a composite of death and MI (OR, 0.67 [95% CI, 0.54–0.83], P <0.001), MI (OR, 0.56 [95% CI, 0.45–0.70], P <0.001) and subsequent revascularization (OR, 0.27 [95% CI, 0.16–0.48], P <0.001). There was no difference in all‐cause death (OR, 0.84 [95% CI, 0.65–1.10], P =0.21), cardiovascular death (OR, 0.85 [95% CI, 0.63–1.15], P =0.30), stroke (OR, 0.74 [95% CI, 0.38–1.47], P =0.39), or major bleeding (OR, 1.24 [95% CI, 0.42–3.66], P =0.70). Conclusions In older patients ≥75 years old with non–ST‐segment–elevation acute coronary syndrome, an invasive strategy reduced the risk of a composite of death and MI, MI, and subsequent revascularization compared with a conservative strategy alone. Older adults with higher burden of geriatric conditions should be included in future trials to improve generalizability to this growing population.
Targeted therapeutic strategies for the kidney
Yuan, Fei , Lerman, Lilach O., Yuan, Fei

Expert Opinion on Therapeutic Targets | November 4, 2024 | Volume: 28 | Issue: 11 | Pages: 979-989

10.1080/14728222.2024.2421756 | PMID 39491501 Get It

Steeper Slope of the Medial Tibial Plateau, Greater Varus Alignment, and Narrower Intercondylar Distance and Notch Width Increase Risk for Medial Meniscus Posterior Root Tears: A Systematic Review
Oeding, Jacob F. , Dean, Michael C. , Krych, Aaron J. , Krych, Aaron J , Dean, M. Wingerchuk , Oeding, Jacob F , Hevesi, Mario , Chahla, Jorge

Arthroscopy | November 4, 2024 | Volume: 41 | Issue: 8 | Pages: 3172

10.1016/j.arthro.2024.10.031 | PMID 39505159 Get It

Purpose To evaluate the available literature on the relationship between knee bony morphology and medial meniscus posterior root tears (MMPRTs) to determine which tibiofemoral morphologic risk factors may predispose the development of MMPRTs. Methods Embase, MEDLINE, and PubMed databases were searched to identify all relevant human clinical studies investigating knee morphologic features and MMPRTs. Shape features were compared between control groups and patients with MMPRTs. The methodological index for nonrandomized studies (MINORS) instrument was utilized to assess the methodological quality of included studies. Results Thirteen level III evidence studies and 1 level IV evidence study were included in this review (n = 2,181), with 895 patients in the MMPRT group and 1,286 in the control group. Tibial morphology features associated with an increased risk for MMPRTs included an increased medial tibial slope (6 studies), increased tibial torsion (1 study), increased medial meniscal slope (1 study), and shallower medial tibial plateau concavity (1 study). Varus mechanical alignment was found to increase the risk for MMPRTs (4 studies). Femoral morphology features associated with an increased risk for MMPRTs included an A‐type intercondylar notch (1 study), increased medial femoral condyle (MFC) angle (1 study), narrower intercondylar distance (1 study), narrower intercondylar notch width (1 study), shorter MFC distal offset distance (1 study), increased MFC width (1 study), increased MFC to medial tibial condyle width ratio (1 study), greater distance between the medial tibial eminence and MFC (1 study), and smaller femoral offset ratios of both the medial and lateral condyles (1 study). Conclusions Multiple tibiofemoral shape features, including a steeper slope of the medial tibial plateau, greater varus alignment, and a narrower intercondylar distance and notch width, were found to be predictive factors for MMPRTs. Level of Evidence Level IV, systematic review of Level III and IV studies.
Patient-Clinician Communication During Cardiology Telemedicine Consultations: A Feasibility Study
Bonner, Timethia , Noss, Bryant, Ennis, Katie, Buckner, Skye A., Milam, Adam J. , Bonner, Timethia J , Buckner, Skye, Milam, Adam J , Hayes, Sharonne N. , Ennis, Katie, Warner, David O.

Journal of Patient Experience | November 4, 2024 | Volume: 11 | Issue: No issue available | Pages: No page available

10.1177/23743735241293618 | PMID 39497930 Get It

While studies have evaluated the utility of telehealth in replacing in-person clinical encounters, there is a dearth of literature examining the quality of patient-physician communication with telehealth encounters. Accordingly, this study assessed the feasibility of using virtual cardiology clinical encounters to examine patient-physician interaction, communication, and perceptions of the clinical encounter. Telemedicine cardiology clinical encounters were audio- and video-recorded following the encounter, patients, and cardiologists completed an electronic survey to assess perceptions of the encounter. Qualitative analysis of the communication and statistical analysis of the survey data was conducted, providing descriptive data. The study included 11 patient-physician dyads; all patients were non-Hispanic White. Cardiologists were more racially and ethnically diverse (63% Asian). Most patients agreed telemedicine was comparable to in-person encounters (85.7%), with all cardiologists reporting that patients appeared satisfied with the encounter. We utilized an assessment tool to examine patient-physician communication in the recorded virtual encounters. This study suggests examining patient-physician communication using virtual clinical encounters is feasible, although there are barriers that need addressing for larger studies.
Imaging Yield and Surgical Outcomes of Nasal, Medial Brow, Forehead, and Scalp Dermoid Cysts
Pazelli, Alexandre Meira, Wang, Leda, Gates-Tanzer, Lauren, Cofer, Shelagh A. , Lehman, Julia S. , Ahn, Edward S. , Gibreel, Waleed , Meira Pazelli, Alexandre, Cofer, Shelagh, Lehman, Julia, Guerin, Julie, Gibreel, Waleed , Lehman, Julia S , Davis, Dawn Marie R. , Mardini, Samir , Guérin, J.

The Cleft Palate Craniofacial Journal | November 4, 2024 | Volume: 63 | Issue: 1 | Pages: 126-132

10.1177/10556656241295572 | PMID 39491820 Get It

Objective Dermoid cyst (DC) is a congenital cyst with the potential to have intracranial extension (ICE). This study aims to evaluate the imaging yield and surgical outcomes of nasal, medial brow, forehead, and scalp DCs. Design Retrospective review of craniofacial DCs treated at our institution between 1992 and 2024. Results A total of 117 patients (57 females) were included. The median age at cyst detection and removal were 4.8 months (IQR 3.6-9.6) and 1.8 years (IQR 0.9-5.3), respectively. In 42 patients, parents have noticed the presence of the cyst immediately after birth. Cyst wall rupture during surgical removal was reported in 15.4%. The median follow-up time was 1.3 months (IQR 0.5-12.2). Three patients experienced recurrence. No postoperative complication was reported. The regions with the highest prevalence of ICE were the forehead, frontotemporal scalp, and nasal region. The lateral frontal/temporal scalp had a 33.3% rate of ICE. Midline forehead/scalp lesions demonstrated a higher risk of ICE compared to their lateral equivalents (54.5% vs 17.5%, P = .03). The sensitivity and specificity of magnetic resonance imaging (MRI) were 100% and 95.7%, while for computed tomography (CT scans) were 72.7% and 96.5%. The Area Under the Curve for MRI was 0.978, and for CT was 0.846. The sensitivity and specificity of ultrasound were 50% and 100%. Conclusions Midline forehead/scalp DCs are more prone to extend intracranially than lateral DCs. MRI had a higher sensitivity and specificity than CT scans in detecting ICE. Routine screening imaging should be considered in midline forehead/scalp, lateral frontal/temporal, and nasal DCs.
Mosaic Copy Number Variation in a Patient with Cerebral and Pulmonary Arteriovenous Malformations and Recurrent Epistaxis
Cyrus, Sharri , Kluge, Michelle L. , Marcou, Cherisse A. , Thorland, Erik C., Baudhuin, Linnea M. , Cyrus, Sharri S, Iyer, Vivek

Clinical Chemistry | November 4, 2024 | Volume: 70 | Issue: 11 | Pages: 1315-1319

10.1093/clinchem/hvae101 | PMID 39489484 Get It

Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study
Flanagan, Kevin C. , Earls, Jon, Hiken, Jeffrey, Wellinghoff, Rachel L., Ponder, Michelle, McLeod, Howard L. , Westra, William H. , Vavinskaya, Vera , Sutton, Leisa , Deichaite, Ida , Macdonald, O. Kenneth, Welaya, Karim, Wade, James L. , Azzi, Georges, Pippas, Andrew W., Slim, Jennifer N. , Bank, Bruce, Sui, Xingwei, Kossman, Steven E., Shenkenberg, Todd D., Alexander, Warren L., Price, Katharine A. , Messina, D. , Glasscock, Jarret , Adkins, Douglas, Ley, Jessica C. , Colevas, Alexander Dimitrios , Cohen, Ezra E.W. , Duncavage, Eric James

Journal for ImmunoTherapy of Cancer | November 3, 2024 | Volume: 12 | Issue: 11 | Pages: e009573

10.1136/jitc-2024-009573 | PMID 39489541 Get It

Background Despite advances in cancer care and detection, >65% of patients with squamous cell cancer of the head and neck (HNSCC) will develop recurrent and/or metastatic disease. The prognosis for these patients is poor with a 5-year overall survival of 39%. Recent treatment advances in immunotherapy, including immune checkpoint inhibitors like pembrolizumab and nivolumab, have resulted in clinical benefit in a subset of patients. There is a critical clinical need to identify patients who benefit from these antiprogrammed cell death protein 1 (anti-PD-1) immune checkpoint inhibitors. Methods Here, we report findings from a multicenter observational study, PREDicting immunotherapy efficacy from Analysis of Pre-treatment Tumor biopsies (PREDAPT), conducted across 17 US healthcare systems. PREDAPT aimed to validate OncoPrism-HNSCC, a clinical biomarker assay predictive of disease control in patients with recurrent or metastatic HNSCC treated with anti-PD-1 immune checkpoint inhibitors as a single agent (monotherapy) and in combination with chemotherapy (chemo-immunotherapy). The test used RNA-sequencing data and machine learning models to score each patient and place them into groups of low, medium, or high. Results The OncoPrism-HNSCC prediction significantly correlated with disease control in both the monotherapy cohort (n=62, p=0.004) and the chemo-immunotherapy cohort (n=50, p=0.01). OncoPrism-HNSCC also significantly predicted progression-free survival in both cohorts (p=0.015 and p=0.037, respectively). OncoPrism-HNSCC had more than threefold higher specificity than programmed death-ligand 1 combined positive score and nearly fourfold higher sensitivity than tumor mutational burden for predicting disease control. Conclusions Here, we demonstrate the clinical validity of the OncoPrism-HNSCC assay in identifying patients with disease control in response to anti-PD-1 immune checkpoint inhibitors. Trial registration number NCT04510129.
The Diagnostic and Therapeutic Dilemma of Multiple Left Ventricular Masses
Youssef, Yasmin H, Issa, Meltiady , Alabdaljabar, Mohamad S. , Youssef, Yasmin H

Journal of Community Hospital Internal Medicine Perspectives | November 3, 2024 | Volume: 14 | Issue: 6 | Pages: 108-110

10.55729/2000-9666.1410 | PMID 39839161 Get It

Intracardiac masses are rare and potentially life-threatening entities with diverse clinical presentations. The prompt identification of cardiac masses is critical. However, even with the advancement we have in imaging modalities, diagnosing cardiac masses remains a formidable challenge. Herein, we present the case of a 62-year-old female who presented with a three-week history of dyspnea and chest pain. Further workup revealed elevated troponins, thrombocytosis, and ST-segment elevation in the anterolateral leads. Chest CT revealed a concerning lung mass, along with vertebral lesions and a large pleural effusion. The patient underwent treatment for suspected myocardial infarction. Additional imaging identified five intracardiac masses in the left ventricle suspicious for either malignancy or thrombi. High-intensity heparin drip was started, yet the patient developed neurological symptoms. Neuroimaging showed new cerebral infarcts. Based on the patient and her family’s wishes, the patient transitioned to comfort care and passed away from gastrointestinal bleeding. In our case, the patient's presentation raised questions about whether her intracardiac masses were malignant or thrombotic. The decision to initiate and maintain anticoagulation therapy constitutes a debate, emphasizing the need for an individualized approach and shared decision-making with the patient and the multidisciplinary team
Prehabilitative/rehabilitative exercise, nutrition, and psychological support for bladder cancer: A scoping review of randomized clinical trials
Parke, Sara C. , Beck, Kelsey L., Sinha, Debarshi, Ligten, Matthew J. Van, Bain, Paul , Tyson, Mark D. , Abdul‐Muhsin, Haidar , Quillen, Jaxon , Luigi, Arthur Jason De , Branstiter, Nikki L., Briggs, Logan G , Parke, Sara C , Gill, Vikram, Van Ligten, Matthew J, Quillen, Jaxon K, Dodoo, Christopher A, Psutka, Sarah P , Briggs, Logan , Sinha, Debarshi, Gill, Vikram S. , Dodoo, Christopher , Trinh, Quoc‐Dien , Psutka, Sarah P.

Cancer | November 3, 2024 | Volume: 131 | Issue: 1 | Pages: No page available

10.1002/cncr.35608 | PMID 39488730 Get It

Abstract The study of prehabilitation and rehabilitation ([p]rehabilitation) to alleviate the sequelae of bladder cancer and its treatment has generated numerous opportunities to improve the quality of life of bladder cancer survivors. The authors conducted a scoping review of randomized clinical trials (RCTs) to identify knowledge gaps in and research directions for (p)rehabilitative support for those affected by bladder cancer. The authors systematically searched six databases and synthesized key findings from RCTs conducted from January 1, 2004, through March 15, 2022, that enrolled participants with bladder cancer, survivors, or caregivers in outpatient (p)rehabilitative programs (e.g., exercise, nutrition, or psychological support). Outcomes were characterized according to eight prespecified, clinically relevant categories. The search retrieved 10,968 records, 27 of which met the inclusion criteria, and 24 described unique RCTs with 2471 enrolled participants. Of 24 interventions, 17 (71%) yielded statistically significant results for the outcome of interest. Only one RCT included a cost‐effectiveness analysis, and only two characterized the efficacy of interventions for caregivers. Of 11 RCTs involving psychological support, eight yielded statistically significant results, as did nine of 11 RCTs with physical exercise interventions, three of four RCTs with educational interventions, three of four RCTs with nutritional support interventions, one of two RCTs with pharmacologic medications, and zero of one RCT with physical therapy. The most promising interventions for inclusion in multimodal, personalized (p)rehabilitation programs included exercise, stress management training, cognitive training, smoking and alcohol cessation counseling, immunonutrition, stoma education, and penile rehabilitation. Further studies of the cost effectiveness and efficacy for caregivers of such interventions are needed. Plain Language Summary In a scoping review of all randomized clinical trials involving prehabilitative or rehabilitative diet, exercise, and psychological support interventions for patients with bladder cancer, survivors, and their caregivers, 17 of 24 (71%) interventions yielded statistically significant improvements in the outcome of interest. Clinicians should consider implementing such interventions for those affected by bladder cancer.